StockData
SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31

DNA X, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$3.31+0.04 (+1.22%)

Close on Oct 19, 2026

Market cap
$4.47M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2026
Ended Mar 31, 2026
Apr 15, 2026After market close–––
Q3 FY2025
Ended Sep 30, 2025
Oct 31, 2025Before market open$16.20M$-4.83–
Q2 FY2025
Ended Jun 30, 2025
Aug 8, 2025During market hours$11.20M$-0.79–
Q1 FY2025
Ended Mar 31, 2025
May 12, 2025During market hours$16.72M$0.08–
Q4 FY2024
Ended Dec 31, 2024
Jan 16, 2025Before market open$15.20M––
Q3 FY2024
Ended Sep 30, 2024
Nov 13, 2024During market hours$15.00M$-0.52–
Q2 FY2024
Ended Jun 30, 2024
Aug 9, 2024During market hours$11.50M$-1.41–
Q1 FY2024
Ended Mar 31, 2024
May 14, 2024During market hours$16.80M$-0.07–
Q4 FY2023
Ended Dec 31, 2023
Mar 27, 2024During market hours–––
Q3 FY2023
Ended Sep 30, 2023
Nov 14, 2023Before market open–––
Q2 FY2023
Ended Jun 30, 2023
Aug 17, 2023Before market open–––
Q1 FY2023
Ended Mar 31, 2023
Apr 25, 2023During market hours–––

Press releases

Announcements DNA X filed with the SEC